LVDT Magazine - Landelijke Vereniging Dialyse en Transplantatie
LVDT Magazine - Landelijke Vereniging Dialyse en Transplantatie
LVDT Magazine - Landelijke Vereniging Dialyse en Transplantatie
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Peritoneale <strong>Dialyse</strong><br />
Optimale oplossing voor het lange verblijf<br />
bij peritoneale dialyse<br />
• Optimaliseert de vochtbalans<br />
3, 4, 5<br />
• Behoudt de klaring<br />
• Minimaliseert de systemisch metabole effect<strong>en</strong> 6<br />
Extraneal Extraneal (Icodextrine 7,5%)<br />
1, 2<br />
• Handhaaft het peritoneale milieu<br />
7, 8, 9, 10, 11<br />
1. ISPD, Evaluation and managem<strong>en</strong>t of ultrafiltration problems in PD. Perit Dial Int 2000;20;S5-S21.<br />
2. Schaubel et al., Tr<strong>en</strong>ds in mortality on PD: Canada 1981-1997.<br />
3. Davies et al., What really happ<strong>en</strong>s to people on long-term PD? Kidney Int 1998;54:2207-2217.<br />
4. CANADA-USA (CANUSA) Peritoneal Dialysis Study Group, Adequacy of dialysis and nutrition in continuous PD:<br />
association with clinical outcomes. J Am Soc Nephrol 1996;7:198-207.<br />
5. Paniagua et al., Effects of increased Peritoneal Clearances on mortality rates in peritoneal dialysis: ADEMEX,<br />
a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13:1307-1320.<br />
6. Martis et al., Conv<strong>en</strong>tional and newer PD solutions in: Dialysis & Transplantation: A Companion to Br<strong>en</strong>ner & Rector’s The Kidney.<br />
Eds. Ow<strong>en</strong> WF., Pereira BJG., Sayhegh MH. WB Saunders 1. Company 2000; pp179-197.<br />
7. Topley, Membrane longevity in PD: impact of infection and bio-incompatible solutions. Adv R<strong>en</strong> Replace Ther 1998;5:179-184.<br />
8. Davies et al., Peritoneal glucose exposure and changes in membrane solute transport with time on PD. J Am Soc Nephrol<br />
2001;12:1046-1051.<br />
9. Honda et al., Accumulation of advanced glycation <strong>en</strong>d products in the peritoneal vasculature of CAPD pati<strong>en</strong>ts with low ulta-filtration.<br />
Nephrol Dial Transplant 1999;14:1541-1549.<br />
10. Davies et al., Longitudinal changes in peritoneal kinetics: the effects of PD and peritonitis. Nephrol Dial Transplant 1996;11:498-506.<br />
11. Coles et al., Peritoneal inflammation and long term changes in peritoneal structure and function in The Textbook of Peritoneal Dialysis.<br />
Eds. Glokal R., Khanna R., Krediet RT. and Nolph KD. Kluwer 2000:pp565-583.<br />
België +32/2 650 17 11 D<strong>en</strong>emark<strong>en</strong> +45/48 16 64 00 Duitsland +49/6221 39 70 Finland<br />
+358/9 862 1111 Frankrijk +33/1 34 61 50 50 Griek<strong>en</strong>land +30/10 9987000 Ierland +353/12<br />
06 5500 Italië +39/02 535 771 Nederland +31/30 24 88 911 Noorweg<strong>en</strong> +47/22 58 48 00<br />
Oost<strong>en</strong>rijk +43/1 711 20-163 Portugal +351/219 25 25 00 Spanje +34/96 386 0800<br />
UK +44/1635 206000 Zwed<strong>en</strong> +46/8 632 64 00 Zwitserland +41/1 908 50 50<br />
Baxter B.V. Kobaltweg 49, 3542 CE Utrecht, Tel. +31(0)30-2488781 Fax. +31(0)30-2488784, www.baxter.nl/R<strong>en</strong>al.htm (E-mail: utrecht.r<strong>en</strong>al@baxter.com)<br />
Copyright 2003. Baxter Healthcare Corporation. All rights reserved.<br />
RR/2004/004
Change language